Bitpanda makes it easy for you to invest in Catalyst Pharmaceuticals from as little as €1. Invest 24/7 with zero commissions and tight spreads.
*Bitpanda Stocks are contracts replicating an underlying stock or ETF.
Create a Bitpanda account and confirm your email address.
Confirm your identity with one of our trusted verification partners and deposit funds.
You’re all set! Start investing with Bitpanda Stocks in Catalyst Pharmaceuticals and over 3,000 other digital assets.
Catalyst Pharmaceuticals is a biopharmaceutical company which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3 and infantile spasms. The company was founded by Huckel E. Hubert and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.